Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02602678
Other study ID # 69HCL15_0430
Secondary ID
Status Completed
Phase N/A
First received November 9, 2015
Last updated January 27, 2016
Start date November 2015
Est. completion date January 2016

Study information

Verified date January 2016
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Acute viral bronchiolitis is the first cause of respiratory distress in infant. Airway inflammation increases the respiratory system resistances and dynamic hyperinflation. This leads to an increase in the work of breathing. In Chronic obstructive pulmonary disease patients as in neonates, prone position (PP) improves lung function and decreases the end expiratory lung volume. The investigators hypothesized that in infants with severe bronchiolitis, prone position reduces the intrinsic Positive End Expiratory Pressure (PEEPi) and the work of breathing (WOB). The investigator designed a prospective randomized crossover study with 16 infants younger than six months who need ventilatory support by nasal continuous positive airway pressure (nCPAP) for severe acute viral bronchiolitis. Work of breathing (product time pressure) and PEEPi will be estimated using an esophageal pressure probe in prone and supine position.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group N/A to 6 Months
Eligibility Inclusion Criteria:

- Infant < 6 months

- Admitted in the pediatric intensive care unit of the Femme-Mère-Enfant hospital, Hospices Civils de Lyon, France

- With severe acute viral bronchiolitis requiring ventilatory support (mWCAS > 4 and/or and or FiO2> 40% and/or hypercapnic acidosis (pH<7.30 and/or pCO2>8 kPa))

- Signed informed consent by the two parents or the owner of parental authority

Exclusion Criteria:

- Chronic respiratory, neuromuscular, ENT or cardiac disease

- Contraindication for placement of esophageal probe (esophageal surgery, varices, …)

- Children requiring invasive ventilation (more than 3 significant apneas in 1 hour, decreased consciousness, …)

- Children not affiliated to a social security scheme

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Supine then Prone position
One hour in supine position with CPAP (+7 cmH2O) then 15 min in supine position in spontaneous ventilation (wash-out) and one hour in prone position with CPAP (+7 cmH2O)
Prone then supine position
One hour in prone position with CPAP (+7 cmH2O) then 15 min in supine position in spontaneous ventilation (wash out ) and one hour in supine position with CPAP (+7 cmH2O)

Locations

Country Name City State
France Hospices Civils de Lyon Bron

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Work of breathing The primary outcome is the work of breathing (WOB) estimated by the mean on 100 breaths of the esophageal and trans-diaphragmatic Pressure-Time Product (PTP) at the end of the first hour. 60 min No
Secondary Intrinsic PEEP Mean on 10 breaths of the intrinsic positive end expiratory pressure in spontaneous ventilation 60 min No
Secondary Inspiratory:Expiratory Time Ratio Mean on 100 breaths of the Inspiratory:Expiratory Time Ratio 60 min No
Secondary Heart rate Evolution of the clinical and oxygenation parameter within the first hour in each position. 60 min No
Secondary Respiratory rate Evolution of the clinical and oxygenation parameters within the first hour in each position. 60 min No
Secondary SPO2 Evolution of the clinical and oxygenation parameters within the first hour in each position. 60 min No
Secondary Transcutaneous CO2 Evolution of the clinical and oxygenation parameters within the first hour in each position. 60 min No
Secondary EDIN score (neonatal pain and discomfort scale) 60 min No